Bradlee Heckmann
![Bradlee Heckmann Bradlee Heckmann](https://proteindegradation.com/wp-content/uploads/sites/82/2024/06/brad-150x150.png)
Company: Asha Therapeutics
Job title: Chief Scientific Officer
Seminars:
Panel Discussion: How Are Regulators & Industry Thinking About Degraders from a Safety Perspective in 2025? 10:00 am
What if anything has changed on the FDA side with regards regulation of degraders? What is the pre-clinical and clinical data telling us thus far for degraders? Where are the opportunities for collaboration between stakeholders to drive these needs forward?Read more
day: Day One AM